Tim O’Brien, MD
Affiliations: | 1993-1995 | University of Oxford, Oxford, United Kingdom |
Website:
https://www.linkedin.com/in/tim-o’brien-472514174/?originalSubdomain=ukGoogle:
"Tim O’Brien"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Warren H, Fernando A, Thomas K, et al. (2019) Surgery for high risk locally advanced (pT3c) renal tumours: Oncological outcomes and prognostic significance of a modified International Metastatic Renal Cell Cancer Database Consortium (IMDC) score. Bju International |
| Turajlic S, Xu H, Litchfield K, et al. (2018) Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal. Cell |
| Mitchell TJ, Turajlic S, Rowan A, et al. (2018) Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal. Cell |
| Powles T, Sarwar N, Stockdale A, et al. (2016) Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer. Jama Oncology |
| Kovac M, Navas C, Horswell S, et al. (2015) Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution. Nature Communications. 6: 6336 |
| Powles T, Blank C, Chowdhury S, et al. (2011) The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer. European Urology. 60: 448-54 |